Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 30

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 30
---
 in excess of those received by the Company upon completion of its IPO, and it may take many years for us to receive marketing approval, if ever, for any in-licensed or acquired product candidate. Relationship with Fortress We have a seven-year operating history. We are a majority owned subsidiary of Fortress. Fortress is a biopharmaceutical company dedicated to acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates at its majority-owned and majority-controlled subsidiaries and joint ventures, and at entities founded by Fortress and in which it maintains significant minority ownership positions. Fortress has a talented and experienced business development team, comprised of scientists, doctors, and finance professionals, who identify, evaluate, and propose for our consideration promising products and product candidates.

<div align='center'>3</div>

Corporate Information

Journey Medical Corporation was incorporated in Delaware in 2014. Our executive offices are located at 9237 E Via de Ventura Blvd. Suite 105, Scottsdale, AZ 85258. Our telephone number is 480-434-6670, and our e-mail address is info@jmcderm.com or ir@jmcderm.com.

We maintain a website with the address www.jmcderm.com.
We make available free of charge through our Internet website our annual reports on Form 10-K, quarterly reports on Form 10-K
and current reports on Form 8-K, and any amendments to these reports, as soon as reasonably practicable after we electronically file
such material with, or furnish such material to, the Securities and Exchange Commission (“SEC”). We are not including the
information on our website as a part of, nor incorporating it by reference into, this report. Additionally, the SEC maintains a website
that contains annual, quarterly, and current reports, proxy statements, and other information that issuers (including us) file electronically
with the SEC. The SEC’s website address is http://www.sec.gov.

Implications of Being an Emerging Growth Company and a Smaller Reporting Company

We are an “emerging growth company”
as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and may remain an emerging growth company
until December 31, 2026, or until such earlier time as we have more than $1.07 billion in annual revenue, we become a “large
accelerated filer” under SEC rules, or we issue more than $1 billion of non-convertible debt over a three-year period